Louise Flanagan
- Molecular Biology
- Hematology top 10%
- Oncology
- Pulmonary and Respiratory Medicine
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Sarah BrownAndrew HallKwee YongJamie CavenaghMartin KaiserEric LowWalter M. GregoryYong Du
- Topics
- Multiple Myeloma Research and Treatments (21 papers)Protein Degradation and Inhibitors (17 papers)Histone Deacetylase Inhibitors Research (7 papers)
- Cited by
- HematologyOncologyMolecular Biology
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
Louise Flanagan
31 papers receiving 296 citations
Peers
Comparison fields: 5 of 50
- Molecular Biology 170
- Hematology 122
- Oncology 109
- Pulmonary and Respiratory Medicine 58
- Radiology, Nuclear Medicine and Imaging 40
Countries citing papers authored by Louise Flanagan
This map shows the geographic impact of Louise Flanagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Flanagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Flanagan more than expected).
Fields of papers citing papers by Louise Flanagan
This network shows the impact of papers produced by Louise Flanagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Flanagan. The network helps show where Louise Flanagan may publish in the future.
Co-authorship network of co-authors of Louise Flanagan
This figure shows the co-authorship network connecting the top 25 collaborators of Louise Flanagan. A scholar is included among the top collaborators of Louise Flanagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Flanagan. Louise Flanagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | 22 | |
| 3 | 17 | |
| 4 | 8 | |
| 5 | 11 | |
| 6 | 3 | |
| 7 | 15 | |
| 8 | 15 | |
| 9 | 13 | |
| 10 | 27 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 25 | |
| 14 | 8 | |
| 15 | 35 | |
| 16 | 9 | |
| 17 | 2 | |
| 18 | 16 | |
| 19 | 3 | |
| 20 | 6 |
About Louise Flanagan
Louise Flanagan is a scholar working on Hematology, Oncology and Molecular Biology, having authored 31 papers that have together received 302 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (21 papers), Protein Degradation and Inhibitors (17 papers) and Histone Deacetylase Inhibitors Research (7 papers). The work is most often cited by research in Hematology (122 citations), Oncology (109 citations) and Molecular Biology (170 citations). Louise Flanagan has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Sarah Brown, Andrew Hall, Kwee Yong, Jamie Cavenagh, Martin Kaiser, Eric Low, Walter M. Gregory, Yong Du, Laura Moss and Jonathan Wadsley. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.